Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Q3 2023 vs. Q2 2023
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 22 | 22 | 0 |
| Shares | 6.53M | 6.18M | −351.0K (−5.4%) |
| Value | $866.3K | $1.64M | +$773.0K (+89.2%) |
New holders (6)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shaolin Capital Management LLC | 650,000 | $143.0K | 0.01% |
| Exos TFP Holdings LLC | 105,000 | $23.1K | 0.01% |
| Sea Otter Advisors LLC | 4,871 | $1.07K | 0.00% |
| Clear Street LLC | 1,946 | $428 | 0.00% |
| Bank of America Corp | 50 | $11 | 0.00% |
| The PNC Financial Services Group, Inc. | 50 | $11 | 0.00% |
Sold out (6)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Radcliffe Capital Management, L.P. | 264,799 | $31.6K |
| Parallax Volatility Advisers, L.P. | 353,227 | $30.1K |
| CNH Partners LLC | 49,304 | $6.41K |
| Alpine Global Management, LLC | 15,400 | $1.75K |
| Flow Traders U.S. LLC | 10,837 | $1.00K |
| Segantii Capital Management Ltd | 25,000 | – |